Sponsor Pipeline

European Institute of Oncology Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
75
Active Trials
56
Recruiting
1
Phase 3
10
Disease Areas
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-09 NCT06474975
Intra-SURGerY High-resolution Specimen PET/CT Imager for Margin Assessment in Early-stage…
overall status: Not Yet Recruiting → Unknown
2026-08-02 NCT06541301
PICC-ports Versus Chest - Ports for Long Term Chemotherapy Deliverance in Oncology…
overall status: Not Yet Recruiting → Unknown
2026-08-02 NCT05963464
RADIOSO MILAN I (RADar Reflector localisatiOn-SCOUT for carcinOma Mammae, the MILAN IEO…
overall status: Recruiting → Unknown
Active Trials by Phase
Phase 4
1
Phase 3
1
Phase 2
6
Not specified
67
Active Trials — top 25 of 75
NCT IDTitleConditionStatus
Phase 4
NCT06972693 NGS-based Germline and Somatic Genetic Test in Ovarian Carcinoma Ovarian Carcinoma Active, Not Recruiting
Phase 3
NCT06611514 Effect of Intravaginal Prasterone on Symptoms of Genitourinary Syndrome of Menopause… Women With Breast Cancer Not Yet Recruiting
Phase 2
NCT05554003 Metronomic Temozolomide in Unfit NENs Patients Metronomic Temozolomide in Unfit Patients… Neuroendocrine Tumors Recruiting
NCT03971045 Pembrolizumab and Oral Metronomic Cyclophosphamide in Patients With Chest Wall Breast… Breast Cancer Recruiting
NCT06690840 Atezolizumab and Chemotherapy Treatment as T-cell Activators in Metastatic Triple… Triple Negative Breast Cancer Recruiting
NCT07395336 Elacestrant and Exemestane for Patients With Pretreated HR+/HER2- Metastatic Breast… Breast Cancer Recruiting
NCT06727357 Next Generation Sequencing-based "Oncochip" for Therapeutic Decision in Metastatic Breast… Breast Cancer, Metastatic Breast Cancer Active, Not Recruiting
NCT06033092 Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion BRCA Mutation Active, Not Recruiting
Not specified
NCT06281210 Vabb After Neoadjuvant Therapy to Avoid Surgery-pCR to Avoid Breast Surgery Breast Cancer Recruiting
NCT06321653 Lymphedema Evaluation After Adjuvant Hypofractionated Radiotherapy for 1-2… Arm Lymphedema Recruiting
NCT06321679 Response Evaluation of Cancer Therapeutics in Metastatic Castration-Resistant Prostate… Castration-resistant Prostate Cancer Recruiting
NCT06327568 Anal Cancer and/or Precancer Screening: Performance Analysis of the BD Onclarity™ HPV… Anal Intraepithelial Neoplasia 2 Recruiting
NCT06331988 Microbiome, Immune-system and Tumor Interaction in Colorectal Cancer Colorectal Cancer Recruiting
NCT06333587 Minimally Invasive Treatments of the Thyroid Papillary Thyroid Microcarcinoma Recruiting
NCT06337760 YOUNg Adults With Gastro-inteSTinal (GI) and nEuroendocrine canceRs. Neuroendocrine Neoplasm Recruiting
NCT05860361 Advanced Proton Therapy Approaches: a Multicenter High-quality Data Registry Cancer Recruiting
NCT04679454 Single Fraction Preoperative Radiotherapy for Early Stage Breast Cancer Breast Cancer Recruiting
NCT05974475 MONDRIAN: Multi-omics Integrative Modelling for Stereotactic Body Radiotherapy in… Lung Neoplasm Malignant Recruiting
NCT06071195 All-in-One Prostate Cancer Staging with MRI Prostate Cancer Recruiting
NCT06706973 Profiling and Targeting Epigenetic Marks to Improve Diagnosis and Therapeutic Approaches… Head and Neck Cancer Recruiting
NCT06703567 IMproving PAtient UndeRstanding of GEP TEst Results: Phase 4 Breast Cancer Recruiting
NCT06727370 Cognitive Screening in Lung Cancer Patients Lung Disease Recruiting
NCT06726889 Increasing Oral Medication Adherence for Metastatic Breast Cancer Patients Breast Cancer Recruiting
NCT06761300 Psychological Assessment in Patients Treated with Spinal Cord Stimulation Spinal Cord Stimulation (SCS) Recruiting
NCT06773624 Use of 68Ga-DOTATOC PET/CT-enterography for Detection of the Primary Lesion in… Small Bowel Neoplasia Recruiting
See all 75 active European Institute of Oncology trials with filters →
Disease Areas
Get alerts when European Institute of Oncology's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free